Lisata Therapeutics Inc.
LSTA | NASDAQ
$1.58
+$0.02 (+1.28%)
Sep 22, 2026, 11:31 AM ET · Market open
Market Data
Market Cap $14.21M
Enterprise Value $3.76M
Beta 0.80
Average Volume 205.15K
Shares Outstanding (Diluted) 9.11M
Shares Change YoY 5.82%
Institutional Ownership 11.74%
Exchange NASDAQ
ISIN US1280583022
Price Performance
Price Change 1M -4.3%
Price Change 3M -55.0%
Price Change 6M -68.9%
Price Change YTD -20.4%
Price Change 1Y -31.9%
Price Change 3Y -24.6%
Price Change 5Y -91.5%
1M CAGR (ann.) 47.2%
1Y CAGR (ann.) -34.7%
5Y CAGR (ann.) -39.1%
All-Time CAGR -37.0%
Valuation
PE Ratio -0.95
Forward PE N/A
PEG Ratio -0.03
Forward PEG -0.15
PS Ratio 142.06
Forward PS 2.80
PB Ratio 1.72
P/FCF Ratio -0.92
P/Adj. FCF Ratio -0.85
P/OCF Ratio -1.16
EV/Sales 37.63
EV/EBIT -0.31
EV/EBITDA -0.31
EV/FCF -0.24
Earnings Yield -105.1%
FCF Yield -108.5%
Adj. FCF Yield -118.3%
Financial Health
Net Cash $10.44M
Total Debt $0
Cash & Short-Term Investments $10.44M
Total Assets $11.03M
Current Ratio 3.69
Quick Ratio 3.69
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -72.56
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 95.0%
Operating Profit Margin -12435.0%
EBITDA Margin -16007.0%
Net Profit Margin -14621.0%
FCF Margin -15406.0%
Adj. FCF Margin -16805.0%
SBC / Revenue 1035.0%
SBC Impact (per share) -9.1%
Returns
Return on Assets -132.6%
Return on Equity -113.8%
Return on Invested Capital -199.1%
Return on Capital Employed -204.3%
Return on Tangible Assets -132.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 12.8%
Revenue CAGR 5Y 54.3%
Revenue CAGR 10Y -43.3%
EPS CAGR 3Y 21.7%
EPS CAGR 5Y 37.2%
EPS CAGR 10Y 7.8%
FCF CAGR 3Y 13.2%
FCF CAGR 5Y 8.9%
FCF CAGR 10Y 1.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 2
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y 666.3%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$1.12
EPS Growth Est (next Q) 129.6%
Revenue Est (next Q) $659K
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-15.41M
Free Cash Flow $-15.41M
Adj. Free Cash Flow $-16.81M
FCF Per Share -$1.35
OCF Per Share -$1.35
OCF/S Ratio -12323.0%
Income Statement
Revenue $100K
Gross Profit $98K
Operating Income $-12.44M
EBITDA $-12.02M
Net Income $-14.62M
EPS (Diluted) -$1.64
Revenue / Employee $4.76K
Profit / Employee $-696.24K
Employees 21
Add to Watchlist
Select watchlists to add or remove LSTA